My site

NEUCHATEL, Switzerland-Monday, August 28th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- Masimo (NASDAQ:MASI) announced today the findings of a recently published study in which researchers in New Delhi, India evaluated the utility of Masimo SpHb®, noninvasive, continuous hemoglobin measurement, during oncosurgery on patients with high anticipated blood loss.1

In the study, Dr. Gupta and colleagues sought to evaluate the utility of SpHb measurements on patients undergoing oncosurgery because oncosurgeries “may be associated with large blood loss, requiring repeated haemoglobin estimation for deciding the need for intraoperative blood transfusion.” They enrolled 50 adult patients with anticipated blood loss of at least 20%. During surgery, the patients’ SpHb was continuously monitored using a Masimo Radical-7® Pulse CO-Oximeter®. The researchers obtained venous blood samples, which were analyzed using a Beckman Coulter analyzer (La ... Read more »

 Speakers from Federal Trade Commission, Department of Justice, and EU Commission 

NEW YORK-Tuesday, August 29th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- Fordham Law School’s 44th Annual International Antitrust Law and Policy Conference in New York City, led for the third year by Fordham Competition Law Institute Director James Keyte, will take place Thursday-Friday, 14-15 September 2017. The conference will feature topics focused the role of the courts in antitrust enforcement, “must-have” content and the antitrust playing field in media and sports, and the multijurisdictional challenge of e-commerce and antitrust.

Keynote speakers include Andrew Finch of the U.S. Department of Justice, Johannes Laitenberger of the EU Commission, Andreas Mundt of the International Competition Network Steering Group, and Maureen Ohlhausen of the U.S. Federal Trade Commission.

Additional speakers include antitrust agency heads Isabelle de Silva ... Read more »

BERLIN-Tuesday, August 29th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- 20th Century Fox, Panasonic Corporation and Samsung Electronics announced today a new partnership to create an open, royalty-free dynamic metadata platform for High Dynamic Range (HDR) through an associated certification and logo program, tentatively called HDR10+. Together, the three companies will form a licensing entity that will begin licensing the HDR10+ platform in January 2018. The entity will license the metadata broadly to content companies, ultra-high definition TVs, Blu-ray disc players/recorders and set-top box manufacturers, as well as SoC vendors, royalty-free with only a nominal administrative fee.

“As leaders in home entertainment content and hardware, the three companies are ideal partners for bringing HDR10+ into the homes of consumers everywhere,” said Jongsuk Chu, Senior Vice President of the Visual Display Business at Samsung Electronics. “We are committed to maki ... Read more »

New movement, enabling a global exchange for innovative minds, doubling entrepreneurial success, increasing prosperity equality

LUCERNE, Switzerland-Tuesday, August 29th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- Approximately 1,200 innovation stakeholders from 50 countries, including entrepreneurs, investors, incubators, accelerators, mentors, and economic development officers expect to join forces for the first time, solving the most burning challenges of entrepreneurship. The World Innovations Forum takes place in Lucerne, Switzerland, June 6 to 8 2018. Doubling entrepreneurial success rate by 2035, creating more equality for prosperity is the main objective. “Our mindset is on global prosperity equality,” said Axel Schultze, co-founder and board member of the WIForum.

Conference topics are reported in advance and include: fundraising, mentorship, taxation, legal barriers, lack of ecosystems, lack of entrepreneurial mindset, societal ... Read more »

 Videos help manufacturers improve process control when dispensing assembly fluids with air-powered benchtop dispensers

EAST PROVIDENCE, R.I.-Thursday, August 24th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- Nordson EFD, a Nordson company (NASDAQ: NDSN) and the world’s leading manufacturer of precision fluid dispensing systems, introduces a new Better Dispensing™ How-To Video series. These three short but highly-educational videos, hosted by EFD Application Specialist Tom Muccino, provide best practices for setting up and troubleshooting benchtop fluid dispensers.

“Sometimes it’s the little things ─ such as making sure there are no contaminants in your plant air supply or that you’re always dispensing in Timed mode ─ that can improve production throughput by applying fluid in a more accurate, repeatable way,” Muccino said. “These videos aim to share often-overlooked best practices that can improve the pe ... Read more »

Ras Al Khaimah, United Arab Emirates -Sunday, August 27th 2017 [ AETOS Wire ]
The regional leading pharmaceutical company Julphar announced today that its Board of Directors has appointed Jerome Carle as General Manager – effective immediately.
The Board expressed confidence in Jerome’s aptitude and competence to make an immediate impact to the business, to lead the management team and to execute the company’s strategic objectives. The Julphar roadmap – Vision 2020 – will be a key pillar to drive Julphar to the top of the MENA markets.
Commenting on his appointment, General Manager Jerome Carle said: “I am very pleased, honored and humbled to have been appointed to this role, and I would like to thank the members of the Board for their trust. I am thrilled to serve a company that makes a real difference in patients and consumers’ quality of life. Julphar is uniquely positioned in the Middle East and African markets to impro ... Read more »

Sensation returns to Dubai for just one night on 10th November and tickets are now on sale

Dubai, United Arab Emirates -Wednesday, August 23rd 2017 [ AETOS Wire ]
Sensation – returns to the City of Gold on November 10 and tickets are now on sale via platinumlist.net.  After three mesmerizing outdoor parties in Dubai, The World’s Leading Dance Event, is proud to announce its much-awaited return with a new show ‘CELEBRATE LIFE’ at Meydan on 10th November 2017.
Several ticket types, including hotel packages and Exclusive VIP tables, are on sale now, via platinumlist.net. You can choose to experience Sensation Dubai through a number of ways; all ticket descriptions and prices can be found online.
Sensation embarked on three beautiful journeys over the last three years when it all began with a deep experience at the “Source of Light”, then glided into the mesmerizing “Ocean of White” and most recently the expe ... Read more »

---New Biotechnology Company Accelerates the Delivery of Transformative Innovations in Treatments of Cancer, Inflammatory & Degenerative Diseases, and Functional Regeneration

---Contributions of Capital, More Than 200+ Issued and Pending Patents, Pre-Clinical and Clinical Assets and Commercial Products Obtained from Companies Including Celgene Corporation, Sorrento Therapeutics (Nasdaq: SRNE), United Therapeutics (Nasdaq: UTHR), and Human Longevity, Inc

WARREN, N.J.-Wednesday, August 23rd 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, United Therapeutics Corporation and Human Longevity, Inc., and entrepreneurial i ... Read more »

LACHEN, Switzerland-Thursday, August 24th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- Octapharma is delighted to announce the publication of interim data from the NuProtect study (GENA-05, NCT01712438), the first clinical data on treatment with Nuwiq® in previously untreated patients (PUPs), on August 16th 2017 as an Early View article in the internationally renowned medical journal Haemophilia.

The NuProtect study was initiated in March 2013 to investigate the immunogenicity, efficacy and safety of Nuwiq® in PUPs with severe haemophilia A, who are at the greatest risk of developing inhibitors. The ongoing study has enrolled 110 PUPs of any age or ethnicity who will receive Nuwiq® for up to 100 exposure days (EDs), making it one of the largest studies with a single FVIII product. Patients who previously received any FVIII concentrates or blood products containing FVIII are excluded from the study.

The recently published article describes interim results ... Read more »

 ● RE-DUAL PCI™ showed large reductions in the incidence of bleeding complications if Pradaxa® dual therapy was used instead of warfarin triple therapy

● Both Pradaxa® doses tested in RE-DUAL PCI™ have been approved for stroke prevention in atrial fibrillation

● Data were presented as a late-breaker at the ESC Congress 20171 and published in the New England Journal of Medicine2

INGELHEIM, Germany-Sunday, August 27th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- The RE-DUAL PCI™ trial explored anticoagulation with Pradaxa® (dabigatran etexilate) dual therapy without aspirin in non-valvular atrial fibrillation (AF) patients following percutaneous coronary intervention (PCI) and stent placement: results showed significantly lower rates of major or clinically relevant non-major bleeding events for dual therapy with Pradaxa® when compared to triple therapy with warfarin.1,2 The risk for the primary safety endpo ... Read more »